Howard Bancorp, Inc. HBMD
23.30 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
23.23 Day range 23.78
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 28.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.30 | 0.30 – 0.30 | 0.24 | +25.0% | 19.62M | -0.3% | 1 |
| Next quarter | 0.25 | 0.25 – 0.25 | 0.33 | -24.2% | 18.37M | -6.7% | 1 |
| Current year | 1.40 | 1.40 – 1.40 | -0.91 | +253.8% | 80.50M | +9.4% | 1 |
| Next year | 1.05 | 1.05 – 1.05 | 1.40 | -25.0% | 76.20M | -5.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 26, 2021 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Jul 15, 2021 | Keefe, Bruyette & Woods | Upgrade | Market Perform | Outperform |
| Apr 27, 2021 | Stephens & Co. | Upgrade | Equal-Weight | Overweight |
| Mar 11, 2021 | Piper Sandler | Initiated | — | Overweight |
| May 1, 2020 | Alden | Upgrade | Neutral | Outperform |
| Feb 20, 2019 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Jul 10, 2018 | Raymond James | Downgrade | Outperform | Market Perform |
| Jun 15, 2018 | Keefe Bruyette & Woods | Initiated | — | Market Perform |
| Feb 9, 2018 | Merion Capital | Upgrade | Neutral | Outperform |
| Oct 20, 2017 | Raymond James | Downgrade | Strong Buy | Outperform |
| Aug 18, 2017 | Stephens & Co. | Upgrade | Equal-Weight | Overweight |
| Aug 10, 2017 | Raymond James | Downgrade | Strong Buy | Outperform |
| Feb 1, 2017 | Raymond James | Initiated | — | Strong Buy |
| Apr 26, 2016 | Merion Capital Group | Upgrade | Neutral | Outperform |
| Nov 23, 2015 | Merion Capital Group | Initiated | — | Neutral |